Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-01

Clinical Trial Update: Corneal Nerves After Treatment With Cenegermin

View source ↗

Summary

This clinical trial update reports on corneal nerve outcomes after treatment with cenegermin in neurotrophic keratitis, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cenegermin (cenegermin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Neurotrophic Keratitis | Status: COMPLETED